emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

► Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Epsilon M&A Deal Report - Easeca

Transaction Multiples for the Valuation of Private Companies

Parthas Holdings / Easeca

No EMAT : 110615
Announced Date : 31/03/2020
Type : Acquisition of Majority Stake
Deal Value : Yes
Acquirer : Parthas Holdings

Target : Easeca
Country : Ireland
Sector of activity :
  • Pharmaceuticals & Cosmetics R&W > Retail and Wholesale ('R&W') > Drugs Retailers
Business Description :
Easeca Ltd wholesales pharmaceutical products.

Transaction multiples available
EV/
Sales		 EV/
Gross Profit		 EV/
EBITDA		 EV/
EBIT		 Eq/
PBT		 P/E Price
to Book		 Specific
multiple(s)
Historic
Current
Rating : **
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Drugs Retailers » = 51
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
02/03/2021 MHP DXB Adam Myers England ** 110483
26/11/2020 Medios Cranach Pharma Germany ** 110471

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report